Selected research
Market Outlook & Growth Opportunities
Global One-Stop Radiotherapy Market Outlook and Growth Opportunities 2026
Market perspective
The global One-Stop Radiotherapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for One-Stop Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for One-Stop Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for One-Stop Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the One-Stop Radiotherapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the One-Stop Radiotherapy market include Dunlee, Varian Medical, Siemens Healthcare, Elekta, Ion Beam Applications, GE Healthcare, Shanghai United Imaging Intelligence and Shanghai Datu Medical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global One-Stop Radiotherapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of One-Stop Radiotherapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents One-Stop Radiotherapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global One-Stop Radiotherapy market.
One-Stop Radiotherapy Segment by Company
Dunlee
Varian Medical
Siemens Healthcare
Elekta
Ion Beam Applications
GE Healthcare
Shanghai United Imaging Intelligence
Shanghai Datu Medical Technology
One-Stop Radiotherapy Segment by Type
Stereotactic Radiosurgery
Stereotactic Body Radiotherapy
Others
One-Stop Radiotherapy Segment by Application
Rectal Cancer
Nasopharyngeal Carcinoma
Bladder Cancer
Lung Cancer
Others
One-Stop Radiotherapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global One-Stop Radiotherapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the One-Stop Radiotherapy key companies, revenue, market share, and recent developments.
3. To split the One-Stop Radiotherapy breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions One-Stop Radiotherapy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify One-Stop Radiotherapy significant trends, drivers, influence factors in global and regions.
6. To analyze One-Stop Radiotherapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global One-Stop Radiotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of One-Stop Radiotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of One-Stop Radiotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global One-Stop Radiotherapy industry.
Chapter 3: Detailed analysis of One-Stop Radiotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of One-Stop Radiotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of One-Stop Radiotherapy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Stereotactic Radiosurgery
- Stereotactic Body Radiotherapy
- Others
Applications
- Rectal Cancer
- Nasopharyngeal Carcinoma
- Bladder Cancer
- Lung Cancer
- Others
Companies covered
- Dunlee
- Varian Medical
- Siemens Healthcare
- Elekta
- Ion Beam Applications
- GE Healthcare
- Shanghai United Imaging Intelligence
- Shanghai Datu Medical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global One-Stop Radiotherapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global One-Stop Radiotherapy Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 One-Stop Radiotherapy Market Dynamics
- 2.1 One-Stop Radiotherapy Industry Trends
- 2.2 One-Stop Radiotherapy Industry Drivers
- 2.3 One-Stop Radiotherapy Industry Opportunities and Challenges
- 2.4 One-Stop Radiotherapy Industry Restraints
3 One-Stop Radiotherapy Market by Company
- 3.1 Global One-Stop Radiotherapy Company Revenue Ranking in 2025
- 3.2 Global One-Stop Radiotherapy Revenue by Company (2021-2026)
- 3.3 Global One-Stop Radiotherapy Company Ranking (2024-2026)
- 3.4 Global One-Stop Radiotherapy Company Manufacturing Base and Headquarters
- 3.5 Global One-Stop Radiotherapy Company Product Type and Application
- 3.6 Global One-Stop Radiotherapy Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global One-Stop Radiotherapy Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 One-Stop Radiotherapy Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 One-Stop Radiotherapy Market by Type
- 4.1 One-Stop Radiotherapy Type Introduction
- 4.1.1 Stereotactic Radiosurgery
- 4.1.2 Stereotactic Body Radiotherapy
- 4.1.3 Others
- 4.2 Global One-Stop Radiotherapy Sales Value by Type
- 4.2.1 Global One-Stop Radiotherapy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global One-Stop Radiotherapy Sales Value by Type (2021-2032)
- 4.2.3 Global One-Stop Radiotherapy Sales Value Share by Type (2021-2032)
5 One-Stop Radiotherapy Market by Application
- 5.1 One-Stop Radiotherapy Application Introduction
- 5.1.1 Rectal Cancer
- 5.1.2 Nasopharyngeal Carcinoma
- 5.1.3 Bladder Cancer
- 5.1.4 Lung Cancer
- 5.1.5 Others
- 5.2 Global One-Stop Radiotherapy Sales Value by Application
- 5.2.1 Global One-Stop Radiotherapy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global One-Stop Radiotherapy Sales Value by Application (2021-2032)
- 5.2.3 Global One-Stop Radiotherapy Sales Value Share by Application (2021-2032)
6 One-Stop Radiotherapy Regional Value Analysis
- 6.1 Global One-Stop Radiotherapy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global One-Stop Radiotherapy Sales Value by Region (2021-2032)
- 6.2.1 Global One-Stop Radiotherapy Sales Value by Region: 2021-2026
- 6.2.2 Global One-Stop Radiotherapy Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America One-Stop Radiotherapy Sales Value (2021-2032)
- 6.3.2 North America One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe One-Stop Radiotherapy Sales Value (2021-2032)
- 6.4.2 Europe One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific One-Stop Radiotherapy Sales Value (2021-2032)
- 6.5.2 Asia-Pacific One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America One-Stop Radiotherapy Sales Value (2021-2032)
- 6.6.2 South America One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa One-Stop Radiotherapy Sales Value (2021-2032)
- 6.7.2 Middle East & Africa One-Stop Radiotherapy Sales Value Share by Country, 2025 VS 2032
7 One-Stop Radiotherapy Country-level Value Analysis
- 7.1 Global One-Stop Radiotherapy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global One-Stop Radiotherapy Sales Value by Country (2021-2032)
- 7.2.1 Global One-Stop Radiotherapy Sales Value by Country (2021-2026)
- 7.2.2 Global One-Stop Radiotherapy Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.3.2 USA One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.7.2 France One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.14.2 China One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.17.2 India One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt One-Stop Radiotherapy Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt One-Stop Radiotherapy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt One-Stop Radiotherapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Dunlee
- 8.1.1 Dunlee Company Information
- 8.1.2 Dunlee Business Overview
- 8.1.3 Dunlee One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
- 8.1.4 Dunlee One-Stop Radiotherapy Product Portfolio
- 8.1.5 Dunlee Recent Developments
- 8.2 Varian Medical
- 8.2.1 Varian Medical Company Information
- 8.2.2 Varian Medical Business Overview
- 8.2.3 Varian Medical One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
- 8.2.4 Varian Medical One-Stop Radiotherapy Product Portfolio
- 8.2.5 Varian Medical Recent Developments
- 8.3 Siemens Healthcare
- 8.3.1 Siemens Healthcare Company Information
- 8.3.2 Siemens Healthcare Business Overview
- 8.3.3 Siemens Healthcare One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
- 8.3.4 Siemens Healthcare One-Stop Radiotherapy Product Portfolio
- 8.3.5 Siemens Healthcare Recent Developments
- 8.4 Elekta
- 8.4.1 Elekta Company Information
- 8.4.2 Elekta Business Overview
- 8.4.3 Elekta One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
- 8.4.4 Elekta One-Stop Radiotherapy Product Portfolio
- 8.4.5 Elekta Recent Developments
- 8.5 Ion Beam Applications
- 8.5.1 Ion Beam Applications Company Information
- 8.5.2 Ion Beam Applications Business Overview
- 8.5.3 Ion Beam Applications One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
- 8.5.4 Ion Beam Applications One-Stop Radiotherapy Product Portfolio
- 8.5.5 Ion Beam Applications Recent Developments
- 8.6 GE Healthcare
- 8.6.1 GE Healthcare Company Information
- 8.6.2 GE Healthcare Business Overview
- 8.6.3 GE Healthcare One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
- 8.6.4 GE Healthcare One-Stop Radiotherapy Product Portfolio
- 8.6.5 GE Healthcare Recent Developments
- 8.7 Shanghai United Imaging Intelligence
- 8.7.1 Shanghai United Imaging Intelligence Company Information
- 8.7.2 Shanghai United Imaging Intelligence Business Overview
- 8.7.3 Shanghai United Imaging Intelligence One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
- 8.7.4 Shanghai United Imaging Intelligence One-Stop Radiotherapy Product Portfolio
- 8.7.5 Shanghai United Imaging Intelligence Recent Developments
- 8.8 Shanghai Datu Medical Technology
- 8.8.1 Shanghai Datu Medical Technology Company Information
- 8.8.2 Shanghai Datu Medical Technology Business Overview
- 8.8.3 Shanghai Datu Medical Technology One-Stop Radiotherapy Revenue and Gross Margin (2021-2026)
- 8.8.4 Shanghai Datu Medical Technology One-Stop Radiotherapy Product Portfolio
- 8.8.5 Shanghai Datu Medical Technology Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst